Here’s What You Need To Know About Medicare’s Game-Changing Drug Negotiations And The First 10 Drugs Under Discussion
The federal government unveiled the initial batch of the ten drugs to be subjected to the first-ever price negotiations by Medicare in collaboration with pharmaceutical companies. There are concerns about the negative impact of this move on drug innovation among a group of businesses. The U.S. Department of Health and Human Services disclosed on Tuesday the selection of the first ten drugs included in Medicare Part D that will undergo negotiation: This assortment encompasses some …